Tags Pharma
Related Use Cases
AI in drug discovery: ADMET property prediction
Discover how artificial intelligence can help you select lead compounds that are both to be effective and do not have adverse effects on patients
Advancing Drug Discovery with Artificial Intelligence
Discover how to enhance your drug discovery pipeline using our novel Artificial Intelligence technology
Related Insights
Wed 11 May 2022
A new AI/ML approach for ligand identification
Only 1% of compound to protein interactions are currently known. We are on a mission to predict the remaining 99%.
Fri 19 Mar 2021
ZeptoNet White Paper: AI for drug discovery
We present ZeptoNet, our novel machine learning technology for in silico small molecule screening at scale
Related News
Mon 30 May 2022
Targeted Protein Degradation : Kantify at Proteocure event
Kantify spoke about the latest progress of AI/ML for Degraders at the event of Proteocure
Fri 19 Mar 2021
Kantify announces its new drug discovery technology
Kantify announces ZeptoNet, its new Virtual screening technology of small molecules
Tue 16 Mar 2021
Kantify at the Belgian AI Week 2021
Kantify is taking part in several events on Artificial Intelligence (AI) during the 2021 Belgian AI Week.